Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses

1 Nov 2018

Abstract excerpt

Mucopolysaccharidoses (MPS) are a group of lysosomal multisystemic, chronic, and progressive diseases characterized by the storage of glycosaminoglycans (GAGs) that may affect the central nervous system. Neuronopathic MPS such as MPS IH, MPS II, MPS IIIA-D, and MPS VII are characterized by neurocognitive regression. In severe MPS I (MPS IH, or Hurler syndrome) initial developmental trajectory is usually...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Family and Disability Support Research
Share to Lysosomal Storage Disorders Research
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30442188
DOI: 10.1186/s13052-018-0561-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidosesPMID 30442188Read ↗

Development and Longitudinal Neurocognitive Functioning in Mucopolysaccharidosis type IIIC: A Case StudySemantic proximity Read ↗

Longitudinal Assessment of Cognitive Development in 23 Patients With Mucopolysaccharidosis (MPS) Type II: Results of up to 14 Years of Follow-Up.Semantic proximity Read ↗

The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype.Semantic proximity Read ↗

Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?Semantic proximity Read ↗

Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.Semantic proximity Read ↗

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.Semantic proximity Read ↗

Degenerative disorders of the central nervous system.Semantic proximity Read ↗

Growth patterns for untreated individuals with MPS I: Report from the international MPS I registry.Semantic proximity Read ↗

Zebrafish models of Mucopolysaccharidosis IIIA, IIIB, and IIIC show hyperactivity, neuroinflammation and changes in oligodendrocyte cell stateSemantic proximity Read ↗

MPS I: Early diagnosis, bone disease and treatment, where are we now?Semantic proximity Read ↗

Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.Semantic proximity Read ↗

Natural history of Sanfilippo syndrome in SpainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.